Get started
CervoMed Inc.CervoMed Inc.CervoMed Inc.

CervoMed Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CRVO chart


Full chart

CRVO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪124.36 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.02 USD
Net income (FY)
‪−16.29 M‬ USD
Revenue (FY)
‪9.74 M‬ USD
Shares float
‪5.64 M‬
Beta (1Y)
1.02

Employees


Employees (FY)
15
Change (1Y)
+7 +87.50%
Revenue / Employee (1Y)
‪649.20 K‬ USD
Net income / Employee (1Y)
‪−1.09 M‬ USD

About CervoMed Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
John J. Alam
Website
cervomed.com
Headquarters
Boston
Founded
1995
FIGI
BBG000N6JH48
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CRVO news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CRVO.

Frequently Asked Questions


The current price of CRVO is 10.71 USD — it has increased by 23.62% in the past 24 hours. Watch CervoMed Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CervoMed Inc. stocks are traded under the ticker CRVO.
CRVO stock has risen by 148.95% compared to the previous week, the month change is a 526.75% rise, over the last year CervoMed Inc. has showed a −53.39% decrease.
We've gathered analysts' opinions on CervoMed Inc. future price: according to them, CRVO price has a max estimate of 21.00 USD and a min estimate of 10.00 USD. Watch CRVO chart and read a more detailed CervoMed Inc. stock forecast: see what analysts think of CervoMed Inc. and suggest that you do with its stocks.
CRVO reached its all-time high on Jun 4, 2001 with the price of 9,000,000.00 USD, and its all-time low was 1.80 USD and was reached on Dec 17, 2024. View more price dynamics on CRVO chart.
See other stocks reaching their highest and lowest prices.
CRVO stock is 48.64% volatile and has beta coefficient of 1.02. Track CervoMed Inc. stock price on the chart and check out the list of the most volatile stocks — is CervoMed Inc. there?
Today CervoMed Inc. has the market capitalization of ‪124.36 M‬, it has increased by 283.47% over the last week.
Yes, you can track CervoMed Inc. financials in yearly and quarterly reports right on TradingView.
CervoMed Inc. is going to release the next earnings report on May 14, 2025. Keep track of upcoming events with our Earnings Calendar.
CRVO earnings for the last quarter are −0.78 USD per share, whereas the estimation was −0.63 USD resulting in a −22.97% surprise. The estimated earnings for the next quarter are −0.62 USD per share. See more details about CervoMed Inc. earnings.
CervoMed Inc. revenue for the last quarter amounts to ‪2.16 M‬ USD, despite the estimated figure of ‪1.53 M‬ USD. In the next quarter, revenue is expected to reach ‪1.45 M‬ USD.
CRVO net income for the last quarter is ‪−6.71 M‬ USD, while the quarter before that showed ‪−4.75 M‬ USD of net income which accounts for −41.07% change. Track more CervoMed Inc. financial stats to get the full picture.
No, CRVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 25, 2025, the company has 15.00 employees. See our rating of the largest employees — is CervoMed Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CervoMed Inc. EBITDA is ‪−18.23 M‬ USD, and current EBITDA margin is −187.18%. See more stats in CervoMed Inc. financial statements.
Like other stocks, CRVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CervoMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CervoMed Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CervoMed Inc. stock shows the neutral signal. See more of CervoMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.